Table 3.
Renal Allograft Loss
| RDP | Control | |||
|---|---|---|---|---|
|
|
||||
| LD (n=277) | DD (n=148) | LD (n=111) | DD (n=221) | |
|
| ||||
| Death with function, n (%) | 139 (50.1) | 82 (55.4) | 52 (46.8) | 117 (52.9) |
| Chronic rejection, n (%) | 33 (11.9) | 15 (10.1) | 20 (18.0) | 33 (14.9) |
| Chronic allograft nephropathy, n (%) | 15 (5.4) | 5 (3.4) | 5 (4.5) | 9 (4.1) |
| Transplant glomerulopathy, n (%) | 18 (6.5) | 6 (4.1) | 2 (1.8) | 4 (1.8) |
| Patient discontinuation of immunosuppressive medications, n (%) | 11 (4.0) | 4 (2.7) | 1 (0.9) | 10 (4.5) |
| Recurrent disease, n (%) | 15 (5.4) | 1 (0.7) | 4 (3.6) | 9 (4.1) |
| Acute rejection, n (%) | 5 (1.8) | 7 (4.7) | 0 (0) | 2 (0.9) |
Abbreviations: RDP, rapid discontinuation of prednisone; LD, living donor; DD, deceased donor.